American Journal of Cardiology
Volume 95, Issue 9 , Pages 1085-1088, 1 May 2005

Effectiveness of Inhibition of Cholesteryl Ester Transfer Protein by JTT-705 in Combination With Pravastatin in Type II Dyslipidemia

  • Jan Albert Kuivenhoven, PhD

      Affiliations

    • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Greetje J. de Grooth, MD, PhD

      Affiliations

    • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Hitoshi Kawamura, PhD

      Affiliations

    • AKROS Pharma Inc., Princeton, New Jersey
    • ,
  • Anke H. Klerkx, PhD

      Affiliations

    • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Francois Wilhelm, MD, PhD

      Affiliations

    • AKROS Pharma Inc., Princeton, New Jersey
    • ,
  • Mieke D. Trip, MD, PhD

      Affiliations

    • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • John J.P. Kastelein, MD, PhD

      Affiliations

    • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationDr. Kastelein's address is: Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, Room F4-159.2, 1105 AZ Amsterdam, The Netherlands

Received 22 July 2004; accepted 16 December 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was supported by a grant from AKROS Pharma Inc., Princeton, New Jersey. Dr. Klerkx was supported by a grant from the Dutch Heart Foundation, Amsterdam, The Netherlands (NHS 2000.073 and NHS 2003B191).

PII: S0002-9149(05)00189-X

doi:10.1016/j.amjcard.2004.12.064

American Journal of Cardiology
Volume 95, Issue 9 , Pages 1085-1088, 1 May 2005

Article Tools